Polysubstance use: Diagnostic challenges, patterns of use and health

Current Opinion in Psychiatry

Volumn 27, Issue 4, 2014, Pages 269-275

  Connor, Jason P ^a,b   Gullo, Matthew J ^a,b   White, Angela ^a   Kelly, Adrian B ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

comorbidity; drugs; polysubstance; prevention; psychopathology

Indexed keywords

ALCOHOL; AMPHETAMINE DERIVATIVE; CANNABIS; ILLICIT DRUG; PRESCRIPTION DRUG; STREET DRUG;

CLINICAL RESEARCH; COGNITION; HEALTH; HEALTH HAZARD; HUMAN; LATENT PERIOD; MENTAL DISEASE; NEUROPSYCHOLOGY; POLYSUBSTANCE USE; REVIEW; SUBSTANCE USE; TOBACCO; TREND STUDY; COMPLICATION; SUBSTANCE-RELATED DISORDERS;

HUMANS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 84901846187     PISSN: 09517367     EISSN: 14736578     Source Type: Journal    
DOI: 10.1097/YCO.0000000000000069     Document Type: Review

References (71)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
2. Hasin DS, O'Brien CP, Auriacombe M, et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry 2013; 170:834-851
3. Darke S, Duflou J, Torok M, Prolov T. Characteristics, circumstances and toxicology of sudden or unnatural deaths involving very high-range alcohol concentrations. Addiction 2013; 108:1411-1417.
4. Wang LJ, Chen YC, Chen CK, et al. Trends in anxiolytic-hypnotic use and polypharmacyinTaiwan 2002-2009: a nationwide, population-based survey. Psychiatr Serv 2014; 65:208-214.
5. Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. Drug Alcohol Depend 2013; 131:263-270.
6. Højsted J, Ekholm O, Kurita GP, et al. Addictive behaviors related to opioid use for chronic pain: a population-based study. Pain 2013; 154:2677-2683.
7. Jones JD, Mogali S, Comer SD. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend 2012; 125:8-18.
8. Trujillo KA, Smith ML, Guaderrama MM. Powerful behavioral interactions between methamphetamine and morphine. Pharmacol Biochem Behav 2011; 99:451-458.
9. Licht CL, Christoffersen M, Okholm M, et al. Simultaneous polysubstance use among Danish 3, 4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases. Hum Psychopharmacol 2012; 27:352-363.
10. Day C, Degenhardt L, Hall W. Changes in the initiation of heroin use after a reduction in heroin supply. Drug Alcohol Rev 2006; 25:307-313.
11. Redonnet B, Chollet A, Fombonne E, et al. Tobacco, alcohol, cannabis and other illegal drug use among young adults: the socioeconomic context. Drug Alcohol Depend 2012; 121:231-239.
12. Fernandez-Calderón F, Lozano OM, Vidal C, et al. Polysubstance use patterns in underground rave attenders: a cluster analysis. J Drug Educ 2011; 41: 183-202.
13. Connor JP, Gullo MJ, Feeney GF, et al. The relationship between cannabis outcome expectancies and cannabis refusal self-efficacy in a treatment population. Addiction 2014; 109:111-119.
14. Gunja N, Brown JA. Energy drinks: health risks and toxicity. Med J Aust 2012; 196:46-49.
15. Ulbrich A, Hemberger SH, Loidl A, et al. Effects of alcohol mixed with energy drink and alcohol alone on subjective intoxication. Amino Acids 2013; 45: 1385-1393.
16. Verster JC, Aufricht C, Alford C. Energy drinks mixed with alcohol: miscon-ceptions, myths, and facts. Int J Gen Med 2012; 5:187-198.
17. Miller P. Energy drinks and alcohol: research supported by industry may be downplaying harms. BMJ 2013; 347:f5345.
18. Chen CM, Yi H-y, Moss HB. Early adolescent patterns of alcohol, cigarettes, and marijuana polysubstance use and young adult substance use: outcomes in a nationally representative sample. Drug Alcohol Depend 2014; 136:51-64.
19. Chiauzzi E, DasMahapatra P, Black RA. Risk behaviors and drug use: a latent class analysis of heavy episodic drinking in first-year college students. Psychol Addict Behav 2013; 27:974-985.
20. Chung T, Kim KH, Hipwell AE, Stepp SD. White and black adolescent females differ in profiles and longitudinal patterns of alcohol, cigarette, and marijuana use. Psychol Addict Behav 2013; 27:1110-1121.
21. Carter JL, Strang J, Frissa S, et al. Comparisons of polydrug use at national and inner city levels in England: associations with demographic and socio economic factors. Ann Epidemiol 2013; 23:636-645.
22. Quek L-H, Chan GCK, White A, et al. Concurrent and simultaneous polydrug use: latent class analysis of an Australian nationally representative sample of young adults. Front Public Health 2013; 1:61.
23. White A, Chan GCK, Quek LH, et al. The topography of multiple drug use among adolescent Australians: findings from the National Drug Strategy Household Survey. Addict Behav 2013; 38:2038-2073.
24. Armour C, Shorter GW, Elhai JD, et al. Polydrug use typologies and childhood maltreatment in a nationally representative survey of Danish young adults. J Stud Alcohol Drugs 2014; 75:170-178.
25. Font-Mayolas S, Gras ME, Cebrián N, et al. Types of polydrug use among Spanish adolescents. Addict Behav 2013; 38:1605-1609.
26. Garcia de Oliveira L, Alberghini DG, dos Santos B, Guerra de Andrade A. Polydrug use among college students in Brazil: a nationwide survey. Rev Bras Psiquiatr 2013; 35:221-230.
27. Reyes CR, Perez CM, Colon HM, et al. Prevalence and patterns of polydrug use in Latin America: analysis of population-based surveys in six countries. Rev Eur Stud 2013; 5:10-18.
28. Measham F, MooreK. Exploring patterns of weekend polydrug use within local leisure scenes across the English night time economy. Criminol Crim Justice 2013; 9:437-464.
29. Herbeck DM, Brecht ML, Lovinger K, et al. Poly-drug and marijuana use among adults who primarily used methamphetamine. J Psychoactive Drugs 2013; 45:132-140.
30. Olthuis JV, Darredeau C, Barrett SP. Substance use initiation: the role of simultaneous polysubstance use. Drug Alcohol Rev 2013; 32:67-71.
31. Smith GW, Farrell M, Bunting BP, et al. Patterns of polydrug use in Great Britain: findings from a national household population survey. Drug Alcohol Depend 2011; 113:222-228.
32. Kelly AB, Chan GCK, White A, et al. Is there any evidence of changes in patterns of concurrent drug use among young Australians 18-29 years between 2007 and 2010? Addictive Behaviors (2014), doi: 10.1016/j. addbeh.2014.04.009
33. Kelly AB, O'Flaherty M, Connor JP, et al. The influence of parents, siblings and peers on pre and early-teen smoking: a multilevel model. Drug Alcohol Rev 2011; 30:381-387.
34. Substance Abuse and Mental Health Services Administration (SAMHSA). The National SurveyonDrug Useand Health (NSDUH)Report: nonmedicaluse of prescription-type drugs, bycounty type. Rockville, MD: Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality; 2013. Retrieved from http://www.samhsa.gov/data/2k13/NSDUH098/ sr098-UrbanRuralRxMisuse.htm. [Accessed 5 February 2014].
35. McCabe SE, West BT. Medical and nonmedical use of prescription benzo-diazepine anxiolytics among U.S. high school seniors. Addict Behav 2014; 39:959-964.
36. Ghandour LA, El Sayed DS, Martins SS. Alcohol and illegal drug use behaviours and prescription opioids use: how do nonmedical and medical users compare, and does motive to use really matter? Eur Addict Res 2013; 19:202-210.
37. Hartung CM, Canu WH, Cleveland CS, et al. Stimulant medication use in college students: comparison of appropriate users, misusers, and nonusers. Psychol Addict Behav 2013; 27:832-840.
38. Fischer B, Ialomiteanu A, Boak A, et al. Prevalence and key covariates of nonmedical prescription opioid use among the general secondary student and adult populations in Ontario, Canada. Drug Alcohol Rev 2013; 32:276-287.
39. Midanik LT, Tam TW, Weisner C. Concurrent and simultaneous drug and alcohol use: results of the 2000 national alcohol survey. Drug Alcohol Depend 2007; 90:72-80.
40. Hedden SL, Martins SS, Malcolm RJ, et al. Patterns of illegal drug use among an adult alcohol dependent population: results from the National Survey on Drug Use and Health. Drug Alcohol Depend 2010; 106:119-125.
41. Connor JP, Gullo MJ, Chan G, et al. Polysubstance use in cannabis users referred for treatment: drug use profiles, psychiatric comorbidity and canna-bis-related beliefs. Front Psychiatry 2013; 4:79.
42. Trenz RC, Scherer M, Duncan A, et al. Latent class analysis of polysubstance use, sexual risk behaviors, and infectious disease among South African drug users. Drug Alcohol Depend 2013; 132:441-448.
43. Harrell PT, Mancha BE, Petras H, et al. Latent classes of heroin and cocaine users predict unique HIV/HCV risk factors. Drug Alcohol Depend 2012; 122:220-227.
44. Andrade LF, Carroll KM, Petry NM. Marijuana use is associated with risky sexual behaviors in treatment-seeking polysubstance abusers. Am J Drug Alcohol Abuse 2013; 39:266-271.
45. Reback CJ, Peck JA, Fletcher JB, et al. Lifetime substance use and HIV sexual risk behaviors predict treatment response to contingency management among homeless, substance-dependent MSM. J Psychoactive Drugs 2012; 44:166-172.
46. Mayer KH, Bush T, Henry K, et al. Ongoing sexually transmitted disease acquisition and risk-taking behavior among US HIV-infected patients in primary care: implications for prevention interventions. Sex Transm Dis 2012; 39:1-7.
47. Brennan J, Kuhns LM, Johnson AK, et al. Adolescent medicine trials network for HIV/AIDS interventions. Syndemic theory and HIV-related risk among young transgender women: the role of multiple, co-occurring health problems and social marginalization. Am J Public Health 2012; 102:1751-1757.
48. Gudin JA, Mogali S, Jones JD, Comer SD. Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use. Postgrad Med 2013; 125:115-130.
49. Licata SC, Renshaw PF. Neurochemistry of drug action. Ann N Y Acad Sci 2010; 1187:148-171.
50. Grodin EN, Lin H, Durkee CA, et al. Deficits in cortical, diencephalic and midbrain gray matter in alcoholism measured by VBM: effects of co-morbid substance abuse. Neuroimage Clin 2013; 2:469-476.
51. Abé C, Mon A, Durazzo TC, et al. Polysubstance and alcohol dependence: unique abnormalities of magnetic resonance-derived brain metabolite levels. Drug Alcohol Depend 2013; 130:30-37.
52. Abé C, Mon A, Hoefer ME, et al. Metabolic abnormalities in lobar and subcortical brain regions of abstinent polysubstance users: magnetic resonance spectroscopic imaging. Alcohol Alcohol 2013; 48:543-551.
53. Sung Y-H, Carey PD, Stein DJ, et al. Decreased frontal N-acetylaspartate levels in adolescents concurrently using both methamphetamine and marijuana. Behav Brain Res 2013; 246:154-161.
54. Di Iorio CR, Watkins TJ, Dietrich MS, et al. Evidence for chronically altered serotonin function in the cerebral cortex of female 3, 4-methylenedioxy-methamphetamine polydrug users. Arch Gen Psychiatry 2012; 69:399-409.
55. Becker B, Wagner D, Koester P, et al. Memory-related hippocampal functioning in ecstasy and amphetamine users: a prospective fMRI study. Psycho-pharmacology 2013; 225:923-934.
56. Watkins TJ, Raj V, Lee J, et al. Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing. Psychopharmacology 2013; 227:41-54.
57. Roberts CA, Fairclough S, Fisk JE, et al. Electrophysiological indices of response inhibition in human polydrug users. J Psychopharmacol 2013; 27:779-789.
58. Koester P, Volz KG, Tittgemeyer M, et al. Decision-making in polydrug amphetamine-type stimulant users: an fMRI study. Neuropsychopharmacol-ogy 2013; 38:1377-1386.
59. Gold MS, Kobeissy FH, Wang KKW, et al. Methamphetamine-and trauma-induced brain injuries: comparative cellular and molecular neurobiological substrates. Biol Psychiatry 2009; 66:118-127.
60. Stavro K, Pelletier J, Potvin S. Widespread and sustained cognitive deficits in alcoholism: a meta-analysis. Addict Biol 2013; 18:203-213.
61. Ioannidis JP. Excess significance bias in the literature on brain volume abnormalities. Arch Gen Psychiatry 2011; 68:773-780.
62. Moreno-López L, Stamatakis EA, Fernández-Serrano MJ, et al. Neural correlates of hot and cold executive functions in polysubstance addiction: association between neuropsychological performance and resting brain metabolism as measured by positron emission tomography. Psychiatry Res 2012; 203: 214-221.
63. Gallagher DT, Hadjiefthyvoulou F, Fisk JE, et al. Prospective memory deficits in illicit polydrug users are associated with the average long-term typical dose of ecstasy typically consumed in a single session. Neuropsychology 2014; 28:43-54.
64. Foxcroft DR, Tsertsvadze A. Cochrane review: universal school-based prevention programs for alcohol misuse in young people. Evid Based Child Health 2012; 7:450-575.
65. Gates S, McCambridge J, Smith LA, Foxcroft DR. Interventions for prevention of drug use by young people delivered in nonschool settings. Cochrane Database Syst Rev 2006; CD005030.
66. Kelly AB, Connor JP. Review: some universal family-based prevention programmes provide small reductions in alcohol use in youths in the short and long term. Evid Based Ment Health 2012; 15:16.
67. Akbar T, Baldacchino A, Cecil J, et al. Poly-substance use and related harms: a systematic review of harm reduction strategies implemented in recreational settings. Neurosci Biobehav Rev 2011; 35:1186-1202.
68. Kelly AB, Connor JP, Toumbourou JW. Substance use disorders in young people: evidence-based prevention and treatment. In: Caltabiano ML, Ric-ciardelli LA, editors. Applied topics in health psychology. United Kingdom: Wiley-Blackwell; 2012. pp. 333-347.
69. Glöckner-Rist A, Lémenager T, Mann K, PREDICT Study Research Group. Reward and relief craving tendencies in patients with alcohol use disorders: results from the PREDICT study. Addict Behav 2013; 38:1532-1540.
70. Newton NC, Teesson M, Barrett EL, et al. The CAP study, evaluation of integrated universal and selective prevention strategies for youth alcohol misuse: study protocol of a cluster randomized controlled trial. BMC Psychiatry 2012; 12:118.
71. Conrod PJ, O'Leary-Barrett M, Newton NC, et al. Effectiveness of a selective personality-targeted prevention program for adolescent alcohol use and misuse. JAMA Psychiatry 2013; 70:334-342.